INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2013
|
Total net assets |
£180.0m |
|
NAV per share |
326.9p |
|
Share price |
289.5p |
|
Total value of unquoted investments |
£24.3m |
|
Total number of portfolio companies |
75 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Biogen |
8.5 |
|
Celgene |
8.2 |
|
Gilead |
7.9 |
|
Amgen |
6.5 |
|
Regeneron |
5.9 |
|
Alexion |
4.0 |
|
Mylan |
3.8 |
|
Incyte |
3.7 |
|
Aptiv |
3.0 |
|
Vertex |
2.7 |
|
|
----------- |
|
Total |
54.2 |
|
Trust Characteristics |
% NAV |
|
Profitable |
59 |
|
Becoming Profitable 2014 |
9 |
|
Unprofitable |
32 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
91 |
|
Europe |
9 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% NAV |
|
Quoted |
86 |
|
Unquoted |
14 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
18 DECEMBER 2013